13 reports

  • HPV Testing
  • Global HPV Test Market

Executive Summary A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of global cervical cancer diagnostics market By Type (Pap Testing, HPV Testing, Colposcopy and Cervical Biopsies),...

  • HPV Testing
  • World
  • Market Size
  • Abbott Laboratories, Inc.
  • Hologic, Inc.
  • HPV TESTING MARKET IN AMERICAS
  • HPV TESTING MARKET IN EMEA

About HPV Testing According to Centers for Disease Control and Prevention (CDC), human papillomavirus (HPV) refers to a group of more than 100 related viruses that commonly cause infections and do not have any symptoms. Among these, more than 40 types of HPVs cause highly contagious diseases that are transmitted through direct sexual...

  • HPV Testing
  • Abbott Laboratories, Inc.
  • Hologic, Inc.
  • QIAGEN N.V.
  • Roche Group

Hoffmann-La Roche Ltd. ##. ## Fujirebio Diagnostics, Inc. ##. ## Hologic, Inc. ##. ## OncoHealth Corporation ##. ## QIAGEN N. V List of Figures FIG. ## Global Cytology and HPV Testing Market Estimates and Forecast, (US$ Mn), 2014–2024 FIG. ## Global HPV Testing Market

  • HPV Testing
  • In Vitro Diagnostics
  • World
  • Market Size
  • HPV TESTING
  • HPV testing

About Cervical Cancer Diagnostic Testing The global cervical cancer diagnostic testing market is growing steadily, primarily due to the availability and awareness of the programs in the developed countries. This test enables women aged 21 years and above to get screened, making most of the pre-cancerous lesions identifiable at stages...

  • Cervical Cancer
  • HPV Testing
  • Sexually Transmitted Disease
  • Hologic, Inc.
  • QIAGEN N.V.

2016 Future Horizons and Growth Strategies in the Global Pap Smear/ HPV Testing Market: Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities (DataPack) List of Tables Major Companies Developing or Marketing Pap Smear/ HPV Tests Franc

  • Diagnostics
  • HPV Testing
  • In Vitro Diagnostics
  • Demand

2016 World Pap Smear/ HPV Market: Emerging Opportunities, Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Landscape--US, Europe, Japan (DataPack) List of Tables Major Companies Developing or Marketing Pap Smear/ HPV

  • Diagnostics
  • HPV Testing
  • Japan
  • United States
  • Demand

This report presents a detailed analysis of the Pap Smear/ HPV testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice; ##-year test volume and sales forecasts by country and market

  • HPV Testing
  • Europe
  • France
  • Demand
  • Forecast

This report presents a detailed analysis of the Pap Smear/ HPV testing market in Europe (France, Germany, Italy, Spain, UK), including clinical significance and current laboratory practice; as well as five-year test volume and sales forecasts by country and market segm

  • HPV Testing
  • Europe
  • France
  • Demand
  • Forecast

2016 Europe Pap Smear/ HPV Market: Emerging Opportunities, Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Landscape--France, Germany, Italy, Spain, UK (DataPack) List of Tables Major Companies Developing or Marketing Pap Smear/

  • HPV Testing
  • France
  • Germany
  • Italy
  • Demand
  • HPV test
  • 6.2 HPV TESTING

Increasing awareness of cervical cancer screening programs, and government initiative and funding are the Major Drivers of the HPV testing and Pap test Market On the basis of test type, the HPV testing and Pap test market is divided into two major segments, namely, HPV testing and Pap test.The HPV testing segment is further classified into...

  • HPV Testing
  • In Vitro Diagnostics
  • Medical Device
  • North America
  • United States
  • May 01, 2017: Genera Biosystems: Quarterly Cash Flow & Business Update for the period ended 31 March 2017

Summary Genera Biosystems Ltd (GBL) is a developer and commercializer of multiplexed molecular diagnostic testing products.The company offers RTIplex and PapType molecular diagnostic test. Its RTIplex is a multiplexed and automated PCR based test for detection of viral and bacterial respiratory pathogens; and PapType...

  • HPV Testing
  • In Vitro Diagnostics
  • Australia
  • Company Financials
  • Genera Biosystems Limited
  • May 01, 2017: Genera Biosystems: Quarterly Cash Flow & Business Update for the period ended 31 March 2017

Summary Genera Biosystems Ltd (GBL) is a developer and commercializer of multiplexed molecular diagnostic testing products.The company offers RTIplex and PapType molecular diagnostic test. Its RTIplex is a multiplexed and automated PCR based test for detection of viral and bacterial respiratory pathogens; and PapType...

  • HPV Testing
  • In Vitro Diagnostics
  • Australia
  • Company Financials
  • Genera Biosystems Limited
  • APR 29, 2014: GENERA BIOSYSTEMS WELCOMES AUSTRALIAN MSAC RECOMMENDATION FOR HPV TESTING AS PRIMARY CERVICAL CANCER SCREENING TOOL
  • SEP 03, 2014: GENERA LODGES TGA APPLICATION FOR CONFORMITY ASSESMENT FOR PAPTYPE HPV ASSAY

Summary Genera Biosystems Ltd (GBL) is a developer and commercializer of multiplexed molecular diagnostic testing products. The company offers RTIplex and PapType molecular diagnostic test. Its RTIplex is a multiplexed and automated PCR based test for detection of viral and bacterial respiratory pathogens; and PapType is...

  • HPV Testing
  • In Vitro Diagnostic Reagent
  • Australia
  • India
  • Genera Biosystems Limited